- Home
- STNG vs APGE Comparison
STNG vs APGE Comparison
Compare STNG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STNG | APGE |
|---|---|---|
| Founded | 2009 | 2022 |
| Country | Monaco | United States |
| Employees | 24 | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | STNG | APGE |
|---|---|---|
| Price | $79.83 | $89.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | $83.33 | ★ $109.67 |
| AVG Volume (30 Days) | 637.4K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.31 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.83 | $34.34 |
| 52 Week High | $87.39 | $95.32 |
Technical Indicators
Market Signals| Indicator | STNG | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 58.46 |
| Support Level | $80.14 | $73.70 |
| Resistance Level | $81.85 | $93.61 |
| Average True Range (ATR) | 2.35 | 5.02 |
| MACD | 0.44 | 0.62 |
| Stochastic Oscillator | 98.96 | 89.73 |
Price Performance
Historical ComparisonAbout STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.